As self-care brand 82 East completes one year and aims to reach the Rs 100-crore ARR mark soon, founders Deepika Padukone and Jigar Shah talk about their R&D, playing to their strengths, and more
Following the Covid-19 pandemic, health and wellness became more important to a lot of Indians, with consumers paying more attention to ingredients and formulations. Consequently, a flurry of startups emerged in the beauty and personal care (BPC) segment to cash in on the trend. Actor and investor Deepika Padukone, too, decided to launch her own skincare brand with a vision to marry Indian ingredients with science-based compounds. She discussed the idea with her fund manager and venture capitalist, Jigar Shah, who had just joined her investment entity, Ka Enterprises.
After two years of planning and research, Padukone and Shah launched direct-to-consumer (D2C), self-care brand 82 East in November 2022. “The uniqueness of our formulations sets us apart in not only the highly competitive Indian market but also on a global scale,” says Shah. The formulations are made by in-house scientists at the company’s R&D centre in Bengaluru, while the products are manufactured by third-party companies. “I'm the first one to try any product. Anything that is out there in the market today, rest assured that I have tried it on first and will give my feedback. And then it goes into trials,” Padukone tells Forbes India.